<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01113762</url>
  </required_header>
  <id_info>
    <org_study_id>VF20050133</org_study_id>
    <nct_id>NCT01113762</nct_id>
  </id_info>
  <brief_title>Metal-metal Articulations Versus Standard 28 mm Cementless Total Hip Arthroplasty</brief_title>
  <official_title>Metal-metal Articulations vs Standard 28 mm Cementless Total Hip Arthroplasty in Younger Patients. Randomized Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of the Interior and Health, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Zealand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>DePuy Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Younger hip patients often need revision of their hip replacement due to wear and loosening.
      Newer concepts (resurfacing and large head total hip replacement) with articulation surfaces
      in metal may reduce the wear, increase the longevity of the implant and give an improved
      function. The possible downside is that these concepts releases metal debris to the body. The
      investigators wish to see if the newer interventions are a clinical improvement compared to
      standard. The investigators also wish to investigate the extent of metal released to the body
      and any effect on the immune system. Finally the investigators wish to investigate the
      stability of these new implants and their ability to preserve the bone around the implant.

      The investigators hypothesis is:

      That the metal on metal articulations will not have better clinical outcomes than standard
      The resurfacing implant is expected to preserve the bone of the upper femoral bone. The
      implants are expected to be stabile within the first year.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Range of motion</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>range of motion in the hip joint evaluated by goniometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of motion</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>Range of motion of the hip joint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of motion</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>range of motion in the hip joint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of motion</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>range of motion in the hip joint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>range of motion</measure>
    <time_frame>2 year +/- 1 month</time_frame>
    <description>range of motion in the hip joint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metal ions</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>Crome and cobalt ions in serum and whole blood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMD</measure>
    <time_frame>Within the first week following surgery</time_frame>
    <description>bone mass density around the implants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RSA</measure>
    <time_frame>Within the first week following surgery</time_frame>
    <description>radiostereommetry. Measurement of micromotions (subsidence, rotation and translations)of the implant in relation to the bone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HHS</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>Harris hip score. An investigator asssesed hip questionnaire including pain, function, deformities and range of motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>University of California Los Angeles activity score. A score over the intensity of activities the patient engages in.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>patient reported outcome of pain, stifness and disability during activities of daily living.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5d</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>a short quality of life measure. patient reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell count</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>quantitative analysis of the level of T-cells in the blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>X-ray</measure>
    <time_frame>within 2 years of surgery</time_frame>
    <description>an assesment of the placement of the metal cup. Inclination and anteversion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>steps</measure>
    <time_frame>Up to two months before surgery</time_frame>
    <description>using a pedometer 1 week prior to each check up the annual step rate is calculated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sick leave</measure>
    <time_frame>assesed 6 months following surgery.</time_frame>
    <description>an assesment of the rehabilitation period following the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metal ions</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>Crom and cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metal ions</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>Crome and cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metal ions</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>crome and cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metal ions</measure>
    <time_frame>2 year +/- 1 month</time_frame>
    <description>crome and cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMD</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>bone mass desity around the implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMD</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>Bone mass density around the implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMD</measure>
    <time_frame>2 year +/- 1 month</time_frame>
    <description>Bone mass density around the implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RSA</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>Radiostereometry of implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RSA</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>Radiostereometry of implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RSA</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>Radiostereometry of implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RSA</measure>
    <time_frame>2 year +/- 1 month</time_frame>
    <description>Radiostereometry of implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HHS</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>Harris hip score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HHS</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>Harris hip score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HHS</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>Harris hip score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HHS</measure>
    <time_frame>2 years +/- 1 month</time_frame>
    <description>Harris hip score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>activity score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>activity score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>activity score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity</measure>
    <time_frame>2 years +/- 1 month</time_frame>
    <description>activity score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC</measure>
    <time_frame>3 weeks</time_frame>
    <description>self reported function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC</measure>
    <time_frame>6 weeks</time_frame>
    <description>self reported function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>self reported function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>self reported function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>self reported function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC</measure>
    <time_frame>2 years +/- 1 month</time_frame>
    <description>self reported function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5d</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5d</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5d</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5d</measure>
    <time_frame>2 years +/- 1 month</time_frame>
    <description>quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell count</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>T cell count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell count</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>T cell count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell count</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>T cell count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell count</measure>
    <time_frame>2 years +/- 1 month</time_frame>
    <description>T cell count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>steps</measure>
    <time_frame>8 weeks +/- 1 week</time_frame>
    <description>steps measured by pedometer during the week prior to check up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>steps</measure>
    <time_frame>6 months +/- 2 weeks</time_frame>
    <description>steps measured by pedometer during the week prior to check up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>steps</measure>
    <time_frame>1 year +/- 1 month</time_frame>
    <description>steps measured by pedometer during the week prior to check up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>steps</measure>
    <time_frame>2 years +/- 1 month</time_frame>
    <description>steps measured by pedometer during the week prior to check up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood loss</measure>
    <time_frame>during surgery</time_frame>
    <description>blood loss measured in mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days in hospital</measure>
    <time_frame>from admission to discharge from hospital</time_frame>
    <description>days in hospital following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>within the first 2 years following surgery</time_frame>
    <description>surgery and implant related complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>surgery time</measure>
    <time_frame>during surgery</time_frame>
    <description>time from skin is incised to skin is closed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incision length</measure>
    <time_frame>during surgery</time_frame>
    <description>the length of the surgical incision in cm</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Osteoarthritis, Hip</condition>
  <arm_group>
    <arm_group_label>resurfacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a hip replacement that leaves most of the underlying bone intact and mimics the natural biomechanical features of the hip joint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>large head THA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a standard stemmed THA but with a large metal head, and a metal-metal articulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>28 mm ceramics-polyethylene</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a standard 28 mm head uncemented THA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>28 mm metal-polyethylene THA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a standard stemmed uncemented THA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>articular surface replacement ASR, DePuy</intervention_name>
    <description>posterolateral incision</description>
    <arm_group_label>resurfacing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReCap/Magnum modular head, Biomet</intervention_name>
    <description>posterolateral incision</description>
    <arm_group_label>large head THA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bimetric stem, mallory/head cup, 28 mm ceramic head, Biomet</intervention_name>
    <description>posterolateral incision</description>
    <arm_group_label>28 mm ceramics-polyethylene</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>28 mm CrCo head, Trilogy CH cup, VerSys Fiber stem,Zimmer)</intervention_name>
    <description>posterolateral incision</description>
    <arm_group_label>28 mm metal-polyethylene THA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary hip osteoarthritis

          -  Secondary osteoarthritis due to mild dysplasia

          -  Age from 40 to 65 years

        Exclusion Criteria:

          -  Dysplasia with CE angle &lt; 25 degrees on the AP projection

          -  Severe femoral head deformation

          -  Reduced femoral neck length

          -  Leg length discrepancy more than 1 cm

          -  Need for restoration of offset

          -  Deformation after fractures or earlier osteotomies

          -  A previous hip arthroplasty

          -  Inflammatory arthritis

          -  Endocrinological disease with bone metabolic manifestations

          -  Renal disease

          -  Malignant disease

          -  Neuro/muscular or vascular diseases of the affected leg

          -  Osteoporosis

          -  Use of opioid pain killers due to other diseases

          -  High dose corticosteroids

          -  Obese with BMI &gt; 35

          -  Pregnant or planning to be

          -  Ppresented problems that would prevent completing our follow-up program
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Soeren Overgaard, MD, professor, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Naestved Hospital Dept. of orthop. surg.</name>
      <address>
        <city>Naestved</city>
        <zip>4700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense University hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.sdu.dk/om_sdu/institutter_centre/klinisk_institut/forskning/forskningsenheder/ortopaedkirurgi.aspx</url>
    <description>the danish homepage for the orthopaedic research unit, university of southern denmark</description>
  </link>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2010</study_first_submitted>
  <study_first_submitted_qc>April 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2010</study_first_posted>
  <last_update_submitted>December 17, 2017</last_update_submitted>
  <last_update_submitted_qc>December 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern Denmark</investigator_affiliation>
    <investigator_full_name>jeannette ostergaard penny</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Arthroplasty, Replacement, Hip</keyword>
  <keyword>Bone Density</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>T-Lymphocytes</keyword>
  <keyword>Chromium Alloys</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cimetidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

